Is Corteva, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Corteva, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its P/E ratio of 37, which exceeds the peer average of 33.44, and a PEG ratio of 2.48, suggesting that the stock is priced high relative to its growth prospects. Additionally, the EV to EBITDA ratio stands at 14.55, which is also on the higher side compared to its peers.
In the Chemicals & Petrochemicals industry, Corteva's key ratios indicate a premium valuation, particularly when compared to peers like BASF with a P/E of 15.2 and Dow Inc. at 18.5. The recent stock performance shows that Corteva has underperformed against the S&P 500 over the past year, returning 4.16% compared to the index's 14.08%, which reinforces the notion of overvaluation in the current market context.